Participation of membrane calcium channels in erythropoietin-induced endothelial cell migration

Calcium (Ca²⁺) plays an important role in angiogenesis, as it activates the cell migration machinery. Different proangiogenic factors have been demonstrated to induce transient Ca²⁺ increases in endothelial cells. This has raised interest in the contribution of Ca²⁺ channels to cell migration, and in a possible use of channel-blocking compounds in angiogenesis-related pathologies. We have investigated the ability of erythropoietin (Epo), a cytokine recently involved in angiogenesis, to induce Ca²⁺ influx through different types of membrane channels in EA.hy926 endothelial cells. The voltage-dependent Ca²⁺ channel antagonists amlodipine and diltiazem inhibited an Epo-triggered transient rise in intracellular Ca²⁺, similarly to a specific inhibitor (Pyr3) and a blocking antibody against the transient potential calcium channel 3 (TRPC3). Unlike diltiazem, amlodipine and the TRPC3 inhibitors prevented the stimulating action of Epo in cell migration and in vitro angiogenesis assays. Amlodipine was also able to inhibit an increase in endothelial cell migration induced by Epo in an inflammatory environment generated with TNF-α. These results support the participation of Ca²⁺ entry through voltage-dependent and transient potential channels in Epo-driven endothelial cell migration, highlighting the antiangiogenic activity of amlodipine.